Inactive Instrument

Insiders Acasti Pharma Inc. Toronto S.E.

Equities

Acasti Pharma Inc. Approves Appointment of Robert J. Delaversano, as Principal Financial Officer and Principal Accounting Officer	Jan. 08	CI
Acasti Pharma Inc. Announces Board Changes	23-10-11	CI
Acasti Pharma Insider Bought Shares Worth $1,249,934, According to a Recent SEC Filing	23-09-28	MT
Acasti Pharma Inc. Announces Scientific Advisory Board Appointments	23-06-22	CI
Acasti Pharma Inc. Announces Executive Changes	23-05-11	CI
Acasti Pharma Inc. Announces CEO Changes	23-04-05	CI
Acasti Pharma Appoints Prashant Kohli as CEO; to Proceed with Phase 3 Clinical Safety Study for GTX-104 Post FDA Feedback	23-04-04	MT
Acasti Pharma Inc. Announces Resignation of Jean-Marie Canan from Board of Directors and Member of Audit Committee and Governance and Human Resources Committee	23-03-30	CI

No results for this search